Objective
Urinary Tract Infection (UTI) is the most common infectious disease seen in humans. Also, UTI ranks as the Number 1 infection that leads to a prescription of antibiotics. Just in 2019, 404,6 million different UTI cases emerged worldwide that costed tens of billions of euros to economies and caused around 236.000 deaths. Luckily, UTIs can be cured effectively with right treatment. The problems need to be resolved are: diagnosing of UTI takes a long time (2-7 days), requires expertise and is costly; high false positive rates and contamination risk causes unnecessary laboratory costs and workload; empirical treatment given without waiting for long culture results leads to unnecessary and/or wrong antibiotic usage and consequently to antibiotic resistance.
As Nanomed Diagnostic, we developed an immunoassay-based point of care test kit for rapid, inexpensive and effortless detection of UTIs (RAPID UTI). It can diagnose UTI just in 5 minutes. It provides at least 10 times less cost for diagnosis by eliminating several technical processes and costly equipment and consumable investments. It eliminates all unnecessary laboratory costs and workload caused by false-positives and contaminated samples. It prevents unnecessary or wrong antibiotic usage and the bacteria to develop resistance to antibiotics.
Within the scope of the 12-month planned project, meetings will be held with European potential customers and distributors, samples will be sent, improvements will be made according to the feedback received, certification studies will be completed, product promotion will be made by participating in fairs, exhibitions and conferences, printed and digital marketing materials will be prepared, and a clinical trial will be conducted in an EU origin institution.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
- natural sciencesbiological sciencesmicrobiologybacteriology
- medical and health sciencesclinical medicineurology
- medical and health scienceshealth sciencesinfectious diseases
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsantibiotics
- medical and health sciencesbasic medicinepharmacology and pharmacydrug resistanceantibiotic resistance
You need to log in or register to use this function
Programme(s)
- HORIZON.3.2 - European innovation ecosystems Main Programme
Funding Scheme
HORIZON-CSA - HORIZON Coordination and Support ActionsCoordinator
34752 Kadikoy, Istanbul
Türkiye
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.